I believe OGXI is currently running a P1 for the stage of bladder cancer that Apaziquone failed in. The 427 P2 trial is for more advanced bladder cancer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.